Preliminary Tolerability Assessment of Naxitamab (Humanized Anti-GD-2 Monoclonal Antibody) Therapy in a Phase 2 Osteosarcoma TrialF. Dela Cruz, A. Chou,S. Roberts,A. Mauguen, J. Bonura, J. Hilliard, M. Namuduri,M. Ortiz, E. Slotkin, L. Wexler,J. Glade Bender, P. Kothari,T. Heaton,M. LaQuaglia,A. Price, P. MeyersPEDIATRIC BLOOD & CANCER(2019)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要